NCT06398418 2025-09-04R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid TumorsRise Therapeutics LLCPhase 1 Recruiting33 enrolled